Balloon-Assisted Transarterial Chemoembolization: A Nascent Strategy for the Treatment of Hepatocellular Carcinoma

Abstract

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide. The majority of newly diagnosed patients are not eligible for curative options, and thus, transarterial therapies such as transarterial chemoembolization (TACE) play a central role in prolonging survival for the majority of patients with liver-confined HCC. Recent developments in microcatheter technology have allowed for increasingly localized intratumoral administration of chemotherapeutic agents as a result of lower profile catheters and occlusion balloon-catheter systems. The purpose of this review is to describe the current state of balloon-assisted transarterial chemoembolization (B-TACE), a nascent transarterial locoregional therapeutic strategy for the treatment of HCC that may confer benefit over conventional TACE (cTACE) in selected patients.

Keywords

hepatocellular carcinoma - TACE - chemoembolization - balloon

• References

• 1 Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2011; 20 (11) 2362-2368
• 2 Lo CM, Ngan H, Tso WK. , et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35 (05) 1164-1171
• 3 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37 (02) 429-442
• 4 Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148 (02) 397-401
• 5 Sasaki Y, Imaoka S, Kasugai H. , et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60 (06) 1194-1203
• 6 Miyayama S, Matsui O, Yamashiro M. , et al. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 2007; 18 (03) 365-376
• 7 Irie T, Kuramochi M, Takahashi N. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 2013; 36 (03) 706-713
• 8 Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30 (05) 969-977
• 9 Kim BK, Kim SU, Kim KA. , et al. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol 2015; 62 (06) 1304-1310
• 10 Miyayama S, Mitsui T, Zen Y. , et al. Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 2009; 39 (04) 374-381
• 11 Murakami R, Yoshimatsu S, Yamashita Y, Sagara K, Arakawa A, Takahashi M. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Acta Radiol 1994; 35 (06) 576-580
• 12 Imai N, Ishigami M, Ishizu Y. , et al. Transarterial chemoembolization for hepatocellular carcinoma: a review of techniques. World J Hepatol 2014; 6 (12) 844-850
• 13 Hoshiai S, Mori K, Ishiguro T. , et al. Balloon-assisted chemoembolization using a micro-balloon catheter alongside a microcatheter for a hepatocellular carcinoma with a prominent arterioportal shunt: a case report. Cardiovasc Intervent Radiol 2017; 40 (04) 625-628
• 14 Miyayama S, Matsui O, Taki K. , et al. Combined use of an occlusion balloon catheter and a microcatheter for embolization of the unselectable right inferior phrenic artery supplying hepatocellular carcinoma. Cardiovasc Intervent Radiol 2004; 27 (06) 677-681
• 15 Matsumoto T, Endo J, Hashida K. , et al. Balloon-occluded transarterial chemoembolization using a 1.8-French tip coaxial microballoon catheter for hepatocellular carcinoma: technical and safety considerations. Minim Invasive Ther Allied Technol 2015; 24 (02) 94-100
• 16 Matsumoto T, Endo J, Hashida K. , et al. Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization. Minim Invasive Ther Allied Technol 2016; 25 (01) 22-28
• 17 Kakuta A, Shibutani K, Ono S. , et al. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization. Hepatol Res 2016; 46 (05) 468-476
• 18 Yoshimatsu R, Yamagami T, Ishikawa M. , et al. Change in imaging findings on angiography-assisted CT during balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2016; 39 (06) 865-874
• 19 Asayama Y, Nishie A, Ishigami K. , et al. Hemodynamic changes under balloon occlusion of hepatic artery: predictor of the short-term therapeutic effect of balloon-occluded transcatheter arterial chemolipiodolization using miriplatin for hepatocellular carcinoma. Springerplus 2016; 5: 157
• 20 Kawamura Y, Ikeda K, Fujiyama S. , et al. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules. Hepatol Res 2017; 47 (04) 338-346
• 21 Ishikawa T, Abe S, Inoue R. , et al. Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma. PLoS One 2014; 9 (07) e103009
• 22 Kudo M, Ueshima K, Kubo S. , et al; Liver Cancer Study Group of Japan. Response evaluation criteria in cancer of the liver (RECICL) (2015 revised version). Hepatol Res 2016; 46 (01) 3-9
• 23 Minami Y, Minami T, Chishina H. , et al. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma: a single-center experience. Oncology 2015; 89 (Suppl. 02) 27-32
• 24 Maruyama M, Yoshizako T, Nakamura T, Nakamura M, Yoshida R, Kitagaki H. Initial experience with balloon-occluded trans-catheter arterial chemoembolization (B-TACE) for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2016; 39 (03) 359-366
• 25 Arai H, Abe T, Takayama H. , et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatol Res 2015; 45 (06) 663-666
• 26 Ogawa M, Takayasu K, Hirayama M. , et al. Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: short-term results. Hepatol Res 2016; 46 (03) E60-E69
• 27 Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatol Res 2016; 46 (02) 209-214
• 28 Golfieri R, Renzulli M, Mosconi C. , et al; Bologna Liver Oncology Group (BLOG). Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?. J Vasc Interv Radiol 2013; 24 (04) 509-517